Anniversary

One-year EXIAS e|1 Analyzer

Despite a turbulent year 2020, we have every reason to celebrate, because our e|1 Analyzer turns one.

On the 15th of November 2019, we were officially CE certified. Consequently, we were able to launch and enter the global market. Today, one year later, we are proud to draw a very pleasant balance.


    50 partners are part of the EXIAS team

    30 countries were trained

    25 registration processes are completed


Our constantly growing network of distributors, as well as the active promotion of the innovative device with its consumables and accessories, enables the analyzer to conquer our target market segments.

Even though the worldwide coronavirus situation affects us since the first quarter of 2020, we experienced a great achievement and a successful first year for the e|1 Analyzer.

Thanks to our partners for their great support and engagement during this exciting year.

THE e|1 ANALYZER - BEST PRACTISE

We have high-quality demands on all components of the e|1 Analyzer.

As a manufacturing company in the medical technology sector, EXIAS is subject to strict regulations and specifications. We intend to ensure that all processes are carried out to the highest possible standards and in accordance with strict quality specifications.

This awareness of quality also applies when we choose our suppliers and partners. Consequently, we entrusted a long-time and experienced manufacturing partner, astria GmbH, with the production of essential components of the EXIAS e|1 Analyzer.

We have been working with astria GmbH as long as we have been in this field of business, in order to provide a high-quality product with the best material properties.
The produced components for our e|1 Analyzer are characterized by their high degree of robustness and flawless design, ensuring perfect application worldwide.

It’s great that not only we, as manufacturer, are convinced by our instrument, even our partner appreciates the quality. Consequently, EXIAS is very proud that our e|1 Analyzer has been named
as best practice by astria GmbH.

Thank you for the successful cooperation over the last years and cheers to further productive projects.

EXIAS GOES DIGITAL VIA ONLINE TRAININGS

Trainings throughout the crisis?
EXIAS makes it possible.

Long-time announced and now it´s released! Today, we are excited to promote our EXIAS online training program. In cooperation with our service and support as well as the marketing and distribution (M&D) department we achieved a comprehensive alternative to our face2face trainings.

Due to persistent flight restrictions we had to adapt our way of doing trainings for 2020 and shifted to a more digital approach.
Therefore, we consecrated ourselves to this challenging task and combined virtual conferencing media with informative and instructive training videos and materials, by not neglecting our important hands-on sessions.

In two-day-sessions we teach our distributors the essential qualifications to operate and service the EXIAS e|1 Analyzer.
Our trainers provide them an overall understanding of the application scope and how they can serve and position the analyzer perfectly within their market.

At EXIAS we are dedicated to the health and well-being of our team. We are blessed to have such a broad network of distributors, who keep our e|1 Analyzer globally up and running.
Consequently, we see it as our duty to equip them with the best possible knowledge and support them throughout this crisis.

 

COVID-19

Measures and actions taken by EXIAS Medical

The global coronavirus situation has impacted Austria like everywhere else. However, we can confidently say, that at EXIAS we have the situation under control. While, the production pipeline is on track, so you can be assured that orders will be shipped on schedule. Current material inventory, guarantees an uninterrupted production of the e|1 Analyzer, as well as its consumables and accessories. Our customer support functions and logistics are available to be contacted as usual. We are reachable via video conferencing, emails and/or phone. In general, EXIAS is up and running
and will support our customers without compromises.

 

However, we want to inform you about the actions taken by EXIAS:


  1. The health and well-being of all our employees is our top priority, therefore the majority of the EXIAS team is working from home, except a few key departments (logistics, production etc.) to keep the business up and running. However, all employees are well-equipped and can be contacted during the usual business hours via video conferences, emails and/or phone.
  2. EXIAS has taken all necessary preparations to guarantee, that the production of the e|1 Analyzer and its consumables can be continued.
  3. Concerning the restrictions taken by the governments, the delivery of goods might be delayed. Nevertheless, EXIAS ensures that all orders will be produced and shipped as fast as possible.
  4. Due to flight restrictions, EXIAS has postponed its upcoming external trainings. We are currently adapting the training plan for the year 2020 and hope to continue with the EXIAS trainings as soon as the situation has calmed down.
  5. In addition, personal meetings with our distributors and partners are rescheduled, as well as events, exhibitions and other fairs are set on hold. These actions will be active as long as the measures taken by the Austrian and international governments are binding.
  6. Further support provides the EXIAS distributor area on our homepage. Here, a comprehensive list of documents, such as training and marketing materials are 24 / 7 available for download.

 

We thank all of you for your understanding and patience during these demanding times. Lastly, we hope that all of us can return soon to our normal daily business. In the meanwhile, stay healthy!

Your EXIAS Medical – Team

EXIAS Medical launches a new generation of electrolyte analyzers

On the way to global market entry

The story of EXIAS Medical is a story which tells continuous growth. Since its foundation, the EXIAS team has tripled and our network of distributors encompasses partners in more than 30 countries.
Our roll-out plan covers a wide range from wholesale markets in Asia to countries in the Middle East and Africa, Eastern Europe and Latin America.

As an aspiring and innovative medical-technology company, we see great potential to revolutionize the existing in vitro diagnostics sector with our e|1 Analyzer.

The EXIAS e|1 Analyzer

Since 2015, our goal has been defined and our timetable was set. Now, we can proudly announce that the last decisive step has been achieved to enter the international market.
On November 15th 2019, our e|1 Analyzer has been officially CE marked and is therefore ready to conquer the market.

High precision, easy operation and the maintenance-free cartridge system underline the functional and outstanding performance of our analyzer. Our innovative concept makes it possible to measure the entire electrolyte spectrum within 25 seconds, which makes it the fastest system on the market. The combination of robust and clever design, as well as its compact footprint make the
e|1 Analyzer ideal for both point-of-care and laboratory use.

The EXIAS e|1 Analyzer makes it possible.

Our sales team is looking forward providing you with more information.